{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:28:35Z","timestamp":1792718915294,"version":"4.5.0"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03368-9","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:21:10Z","timestamp":1772065270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bridging Gaps in Fungal Keratitis Management: Novel Diagnostics, Drug Delivery Systems, and Gene Therapies"],"prefix":"10.1208","volume":"27","author":[{"given":"Riya","family":"Shivgotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossamaldeen","family":"Bakrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-941X","authenticated-orcid":false,"given":"Subheet Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"6","key":"3368_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061178","volume":"10","author":"KA Knutsson","year":"2021","unstructured":"Knutsson KA, Iovieno A, Matuska S, Fontana L, Rama P. Topical corticosteroids and fungal keratitis: a review of the literature and case series. J Clin Med. 2021;10(6): 1178. https:\/\/doi.org\/10.3390\/jcm10061178.","journal-title":"J Clin Med"},{"issue":"6","key":"3368_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-023-03536-6","volume":"205","author":"P Reginatto","year":"2023","unstructured":"Reginatto P, Agostinetto GD, Fuentefria RD, Marinho DR, Pizzol MD, Fuentefria AM. Eye fungal infections: a mini review. Arch Microbiol. 2023;205(6): 236. https:\/\/doi.org\/10.1007\/s00203-023-03536-6.","journal-title":"Arch Microbiol"},{"issue":"3","key":"3368_CR3","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/S1473-3099(20)30448-5","volume":"21","author":"L Brown","year":"2021","unstructured":"Brown L, Leck AK, Gichangi M, Burton MJ, Denning DW. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021;21(3):e49-57. https:\/\/doi.org\/10.1016\/S1473-3099(20)30448-5.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3368_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40588-020-00142-8","volume":"7","author":"R Rammohan","year":"2020","unstructured":"Rammohan R, Suneetha V, Sen S, Rameshkumar G, Lalitha P. Fungal infections of the eye. Curr Clin Microbiol Rep. 2020;7(3):39\u201350. https:\/\/doi.org\/10.1007\/s40588-020-00142-8.","journal-title":"Curr Clin Microbiol Rep"},{"issue":"4","key":"3368_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040273","volume":"7","author":"JJ Hoffman","year":"2021","unstructured":"Hoffman JJ, Burton MJ, Leck A. Mycotic keratitis\u2014a global threat from the filamentous fungi. J Fungi. 2021;7(4): 273. https:\/\/doi.org\/10.3390\/jof7040273.","journal-title":"J Fungi"},{"key":"3368_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S447138","author":"R Awad","year":"2024","unstructured":"Awad R, Ghaith AA, Awad K, Mamdouh Saad M, Elmassry AA. Fungal keratitis: diagnosis, management, and recent advances. Clin Ophthalmol. 2024. https:\/\/doi.org\/10.2147\/OPTH.S447138.","journal-title":"Clin Ophthalmol"},{"key":"3368_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jtos.2021.12.001","volume":"24","author":"N Sharma","year":"2022","unstructured":"Sharma N, Bagga B, Singhal D, Nagpal R, Kate A, Saluja G, et al. Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes. Ocul Surf. 2022;24:22\u201330. https:\/\/doi.org\/10.1016\/j.jtos.2021.12.001.","journal-title":"Ocul Surf"},{"issue":"10","key":"3368_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/jof8101078","volume":"8","author":"MC Ram\u00edrez-Soto","year":"2022","unstructured":"Ram\u00edrez-Soto MC, Bonifaz A. Ocular fungal infections. J Fungi. 2022;8(10):1078. https:\/\/doi.org\/10.3390\/jof8101078.","journal-title":"J Fungi"},{"issue":"1","key":"3368_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010161","volume":"12","author":"LA Ghenciu","year":"2024","unstructured":"Ghenciu LA, Faur AC, Bolintineanu SL, Salavat MC, Maghiari AL. Recent advances in diagnosis and treatment approaches in fungal keratitis: a narrative review. Microorganisms. 2024;12(1): 161. https:\/\/doi.org\/10.3390\/microorganisms12010161.","journal-title":"Microorganisms"},{"key":"3368_CR10","doi-asserted-by":"publisher","first-page":"108372","DOI":"10.1016\/j.exer.2020.108372","volume":"202","author":"B Mills","year":"2021","unstructured":"Mills B, Radhakrishnan N, Rajapandian SG, Rameshkumar G, Lalitha P, Prajna NV. The role of fungi in fungal keratitis. Exp Eye Res. 2021;202:108372. https:\/\/doi.org\/10.1016\/j.exer.2020.108372.","journal-title":"Exp Eye Res"},{"issue":"7","key":"3368_CR11","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1021\/acsinfecdis.4c00203","volume":"10","author":"AC Bisen","year":"2024","unstructured":"Bisen AC, Sanap SN, Agrawal S, Biswas A, Mishra A, Verma SK, et al. Etiopathology, epidemiology, diagnosis, and treatment of fungal keratitis. ACS Infect Dis. 2024;10(7):2356\u201380. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00203.","journal-title":"ACS Infect Dis"},{"issue":"12","key":"3368_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/myc.12822","volume":"61","author":"S Mahmoudi","year":"2018","unstructured":"Mahmoudi S, Masoomi A, Ahmadikia K, Tabatabaei SA, Soleimani M, Rezaie S, et al. Fungal keratitis: an overview of clinical and laboratory aspects. Mycoses. 2018;61(12):916\u201330. https:\/\/doi.org\/10.1111\/myc.12822.","journal-title":"Mycoses"},{"issue":"1\u20132","key":"3368_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijpharm.2007.04.028","volume":"344","author":"K Morand","year":"2007","unstructured":"Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int J Pharm. 2007;344(1\u20132):150\u20133. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.04.028.","journal-title":"Int J Pharm"},{"issue":"1","key":"3368_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15171\/bi.2016.07","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar J, Aghanejad A, Fathi M, Omidi Y. Advanced drug delivery and targeting technologies for the ocular diseases. Bioimpacts. 2016;6(1):49. https:\/\/doi.org\/10.15171\/bi.2016.07.","journal-title":"Bioimpacts"},{"key":"3368_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.colcom.2024.100794","volume":"61","author":"YX Guo","year":"2024","unstructured":"Guo YX, He YX. Nanoparticle-based drug delivery systems: an updated strategy for treating fungal keratitis. Colloid Interface Sci Commun. 2024;61: 100794. https:\/\/doi.org\/10.1016\/j.colcom.2024.100794.","journal-title":"Colloid Interface Sci Commun"},{"issue":"2","key":"3368_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41881","volume":"11","author":"MF Tafti","year":"2025","unstructured":"Tafti MF, Fayyaz Z, Aghamollaei H, Jadidi K, Faghihi S. Drug delivery strategies to improve the treatment of corneal disorders. Heliyon. 2025;11(2): e2477. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41881.","journal-title":"Heliyon"},{"issue":"3","key":"3368_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/02713683.2010.533810","volume":"36","author":"A Kalkanci","year":"2011","unstructured":"Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011;36(3):179\u201389. https:\/\/doi.org\/10.3109\/02713683.2010.533810.","journal-title":"Curr Eye Res"},{"issue":"4","key":"3368_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41433-020-01339-3","volume":"35","author":"DS Ting","year":"2021","unstructured":"Ting DS, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye. 2021;35(4):1084\u2013101. https:\/\/doi.org\/10.1038\/s41433-020-01339-3.","journal-title":"Eye"},{"issue":"3","key":"3368_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12281-023-00468-y","volume":"17","author":"Z Pek","year":"2023","unstructured":"Pek Z, Bork JT. A scoping review of the changing epidemiology and risk factors of endogenous Candida ocular infections. Curr Fungal Infect Rep. 2023;17(3):188\u201394. https:\/\/doi.org\/10.1007\/s12281-023-00468-y.","journal-title":"Curr Fungal Infect Rep"},{"issue":"3","key":"3368_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.survophthal.2021.08.002","volume":"67","author":"C Donovan","year":"2022","unstructured":"Donovan C, Arenas E, Ayyala RS, Margo CE, Espana EM. Fungal keratitis: mechanisms of infection and management strategies. Surv Ophthalmol. 2022;67(3):758\u201369. https:\/\/doi.org\/10.1016\/j.survophthal.2021.08.002.","journal-title":"Surv Ophthalmol"},{"key":"3368_CR21","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2147\/OPTH.S219264","volume":"13","author":"L Spadea","year":"2019","unstructured":"Spadea L, Giannico MI. Diagnostic and management strategies of Aspergillus endophthalmitis: current insights. Clin Ophthalmol. 2019;13:2573\u201382. https:\/\/doi.org\/10.2147\/OPTH.S219264.","journal-title":"Clin Ophthalmol"},{"key":"3368_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.eye.6700557","volume":"17","author":"P Thomas","year":"2003","unstructured":"Thomas P. Fungal infections of the cornea. Eye. 2003;17:852\u201362. https:\/\/doi.org\/10.1038\/sj.eye.6700557.","journal-title":"Eye"},{"issue":"4","key":"3368_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1128\/cmr.13.4.662","volume":"13","author":"SA Klotz","year":"2000","unstructured":"Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13(4):662\u201385. https:\/\/doi.org\/10.1128\/cmr.13.4.662.","journal-title":"Clin Microbiol Rev"},{"key":"3368_CR24","doi-asserted-by":"publisher","unstructured":"Gentile P, Ragusa E, Bruno R, Ceccarelli F, Adani C, Bolletta E et al (2025) Endogenous Candida endophthalmitis: an update on epidemiological, pathogenetic, clinical, and therapeutic aspects. Ocul Immunol Inflamm 1\u20137.  https:\/\/doi.org\/10.1080\/09273948.2025.2524013.","DOI":"10.1080\/09273948.2025.2524013"},{"issue":"11","key":"3368_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jof7110907","volume":"7","author":"N Raj","year":"2021","unstructured":"Raj N, Vanathi M, Ahmed NH, Gupta N, Lomi N, Tandon R. Recent perspectives in the management of fungal keratitis. J Fungi. 2021;7(11): 907. https:\/\/doi.org\/10.3390\/jof7110907.","journal-title":"J Fungi"},{"issue":"23","key":"3368_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314933","volume":"23","author":"N Fortingo","year":"2022","unstructured":"Fortingo N, Melnyk S, Sutton SH, Watsky MA, Bollag WB. Innate immune system activation, inflammation and corneal wound healing. Int J Mol Sci. 2022;23(23): 14933. https:\/\/doi.org\/10.3390\/ijms232314933.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3368_CR27","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1007\/s00018-020-03736-z","volume":"78","author":"AB Strickland","year":"2021","unstructured":"Strickland AB, Shi M. Mechanisms of fungal dissemination. Cell Mol Life Sci. 2021;78(7):3219\u201338. https:\/\/doi.org\/10.1007\/s00018-020-03736-z.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"3368_CR28","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1021\/acsinfecdis.4c00442","volume":"10","author":"H Bihaniya","year":"2024","unstructured":"Bihaniya H, Rudraprasad D, Joseph J. Pathobiology of fungal endophthalmitis: a major review. ACS Infect Dis. 2024;10(9):3126\u201337. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00442.","journal-title":"ACS Infect Dis"},{"key":"3368_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01968","volume":"8","author":"JF Kernien","year":"2018","unstructured":"Kernien JF, Snarr BD, Sheppard DC, Nett JE. The interface between fungal biofilms and innate immunity. Front Immunol. 2018;8: 1968. https:\/\/doi.org\/10.3389\/fimmu.2017.01968.","journal-title":"Front Immunol"},{"key":"3368_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103802","volume":"138","author":"L Niu","year":"2020","unstructured":"Niu L, Liu X, Ma Z, Yin Y, Sun L, Yang L, et al. Fungal keratitis: pathogenesis, diagnosis and prevention. Microb Pathog. 2020;138: 103802. https:\/\/doi.org\/10.1016\/j.micpath.2019.103802.","journal-title":"Microb Pathog"},{"issue":"2","key":"3368_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ni.2797","volume":"15","author":"PR Taylor","year":"2014","unstructured":"Taylor PR, Roy S, Leal SM Jr, Sun Y, Howell SJ, Cobb BA, et al. Activation of neutrophils by autocrine IL-17A\u2013IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, ROR\u03b3t and dectin-2. Nat Immunol. 2014;15(2):143\u201351. https:\/\/doi.org\/10.1038\/ni.2797.","journal-title":"Nat Immunol"},{"issue":"3","key":"3368_CR32","doi-asserted-by":"publisher","first-page":"e0214076","DOI":"10.1371\/journal.pone.0214076","volume":"14","author":"P Jrmaongkhajornpong","year":"2019","unstructured":"Jrmaongkhajornpong P, Nimworaphan J, Lekhanont K, Chuckpaiwong V, Rattanasiri S. Predicting factors and prediction model for discriminating between fungal infection and bacterial infection in severe microbial keratitis. PLoS ONE. 2019;14(3):e0214076. https:\/\/doi.org\/10.1371\/journal.pone.0214076.","journal-title":"PLoS ONE"},{"issue":"3","key":"3368_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.sjopt.2019.09.002","volume":"33","author":"HM Alkatan","year":"2019","unstructured":"Alkatan HM, Al-Essa RS. Challenges in the diagnosis of microbial keratitis: a detailed review with update and general guidelines. Saudi J Ophthalmol. 2019;33(3):268\u201376. https:\/\/doi.org\/10.1016\/j.sjopt.2019.09.002.","journal-title":"Saudi J Ophthalmol"},{"issue":"9","key":"3368_CR34","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.4103\/ijo.IJO_3685_20","volume":"69","author":"VM Rathi","year":"2021","unstructured":"Rathi VM, Murthy SI, Mitra S, Yamjala B, Mohamed A, Sharma S. Masked comparison of trypan blue stain and potassium hydroxide with calcofluor white stain in the microscopic examination of corneal scrapings for the diagnosis of microbial keratitis. Indian J Ophthalmol. 2021;69(9):2457\u201360. https:\/\/doi.org\/10.4103\/ijo.IJO_3685_20.","journal-title":"Indian J Ophthalmol"},{"key":"3368_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001338","volume":"36","author":"H Eguchi","year":"2017","unstructured":"Eguchi H, Hotta F, Kuwahara T, Imaohji H, Miyazaki C, Hirose M, et al. Diagnostic approach to ocular infections using various techniques from conventional culture to next-generation sequencing analysis. Cornea. 2017;36: S46. https:\/\/doi.org\/10.1097\/ICO.0000000000001338.","journal-title":"Cornea"},{"key":"3368_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/08820538.2010.518516","volume":"25","author":"RL Kumar","year":"2010","unstructured":"Kumar RL, Cruzat A, Hamrah P. Current state of in vivo confocal microscopy in management of microbial keratitis. Semin Ophthalmol. 2010;25:166\u201370. https:\/\/doi.org\/10.3109\/08820538.2010.518516.","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"3368_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ceo.14113","volume":"50","author":"M Cabrera\u2010Aguas","year":"2022","unstructured":"Cabrera\u2010Aguas M, Khoo P, Watson SL. Infectious keratitis: a review. Clin Exp Ophthalmol. 2022;50(5):543\u201362. https:\/\/doi.org\/10.1111\/ceo.14113.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"3368_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ophtha.2010.05.018","volume":"118","author":"PK Vaddavalli","year":"2011","unstructured":"Vaddavalli PK, Garg P, Sharma S, Sangwan VS, Rao GN, Thomas R. Role of confocal microscopy in the diagnosis of fungal and Acanthamoeba keratitis. Ophthalmology. 2011;118(1):29\u201335. https:\/\/doi.org\/10.1016\/j.ophtha.2010.05.018.","journal-title":"Ophthalmology"},{"issue":"11","key":"3368_CR39","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.03.134","volume":"8","author":"J Lv","year":"2020","unstructured":"Lv J, Zhang K, Chen Q, Chen Q, Huang W, Cui L, et al. Deep learning-based automated diagnosis of fungal keratitis with in vivo confocal microscopy images. Ann Transl Med. 2020;8(11): 706. https:\/\/doi.org\/10.21037\/atm.2020.03.134.","journal-title":"Ann Transl Med"},{"issue":"7","key":"3368_CR40","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1007\/s10792-022-02616-8","volume":"43","author":"N Ghouneimy","year":"2023","unstructured":"Ghouneimy N, Huang G, Lei D, Jiang L, Chen Q, He W, et al. An artificial intelligence approach to classify pathogenic fungal genera of fungal keratitis using corneal confocal microscopy images. Int Ophthalmol. 2023;43(7):2203\u201314. https:\/\/doi.org\/10.1007\/s10792-022-02616-8.","journal-title":"Int Ophthalmol"},{"issue":"7","key":"3368_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071246","volume":"11","author":"N Hung","year":"2021","unstructured":"Hung N, Shih AK, Lin C, Kuo MT, Hwang YS, Wu WC, et al. Using slit-lamp images for deep learning-based identification of bacterial and fungal keratitis: model development and validation with different convolutional neural networks. Diagnostics. 2021;11(7): 1246. https:\/\/doi.org\/10.3390\/diagnostics11071246.","journal-title":"Diagnostics"},{"issue":"12","key":"3368_CR42","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1080\/02713683.2020.1772830","volume":"45","author":"M Roth","year":"2020","unstructured":"Roth M, Daas L, MacKenzie CR, Balasiu A, Stachon T, Neumann I, et al. Development and assessment of a simulator for in vivo confocal microscopy in fungal and Acanthamoeba keratitis. Curr Eye Res. 2020;45(12):1484\u20139. https:\/\/doi.org\/10.1080\/02713683.2020.1772830.","journal-title":"Curr Eye Res"},{"key":"3368_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.797616","volume":"8","author":"F Xu","year":"2021","unstructured":"Xu F, Jiang L, He W, Huang G, Hong Y, Tang F, et al. The clinical value of explainable deep learning for diagnosing fungal keratitis using in vivo confocal microscopy images. Front Med. 2021;8: 797616. https:\/\/doi.org\/10.3389\/fmed.2021.797616.","journal-title":"Front Med"},{"issue":"1","key":"3368_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12348-011-0019-9","volume":"1","author":"C Ferrer","year":"2011","unstructured":"Ferrer C, Ali\u00f3 JL. Evaluation of molecular diagnosis in fungal keratitis: ten years of experience. J Ophthalmic Inflamm Infect. 2011;1(1):15\u201322. https:\/\/doi.org\/10.1007\/s12348-011-0019-9.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"3368_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010286","volume":"13","author":"P Toumasis","year":"2024","unstructured":"Toumasis P, Tsantes AG, Tsiogka A, Samonis G, Vrioni G. From clinical suspicion to diagnosis: a review of diagnostic approaches and challenges in fungal keratitis. J Clin Med. 2024;13(1): 286. https:\/\/doi.org\/10.3390\/jcm13010286.","journal-title":"J Clin Med"},{"issue":"9","key":"3368_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/myc.13618","volume":"66","author":"Y Tawde","year":"2023","unstructured":"Tawde Y, Das S, Gupta A, Sharma S, Basak S, Shrimali T, et al. Development of single\u2010tube real\u2010time PCR assay for the rapid detection of Aspergillus and Fusarium\u2014the two most common causative agents in fungal keratitis. Mycoses. 2023;66(9):801\u20139. https:\/\/doi.org\/10.1111\/myc.13618.","journal-title":"Mycoses"},{"issue":"3","key":"3368_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/OPX.0000000000001652","volume":"98","author":"HS Behera","year":"2021","unstructured":"Behera HS, Srigyan D. Evaluation of polymerase chain reaction over routine microbial diagnosis for the diagnosis of fungal keratitis. Optom Vis Sci. 2021;98(3):280\u20134. https:\/\/doi.org\/10.1097\/OPX.0000000000001652.","journal-title":"Optom Vis Sci"},{"issue":"2","key":"3368_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18869\/acadpub.cmm.1.2.31","volume":"1","author":"I Haghani","year":"2015","unstructured":"Haghani I, Amirinia F, Nowroozpoor-Dailami K, Shokohi T. Detection of fungi by conventional methods and semi-nested PCR in patients with presumed fungal keratitis. Curr Med Mycol. 2015;1(2):31\u20138. https:\/\/doi.org\/10.18869\/acadpub.cmm.1.2.31.","journal-title":"Curr Med Mycol"},{"issue":"9","key":"3368_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098146","volume":"24","author":"S Sugita","year":"2023","unstructured":"Sugita S, Takase H, Nakano S. Role of recent PCR tests for infectious ocular diseases: from laboratory-based studies to the clinic. Int J Mol Sci. 2023;24(9): 8146. https:\/\/doi.org\/10.3390\/ijms24098146.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3368_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071539","volume":"9","author":"E Torres-Sangiao","year":"2021","unstructured":"Torres-Sangiao E, Leal Rodriguez C, Garc\u00eda-Riestra C. Application and perspectives of MALDI-TOF mass spectrometry in clinical microbiology laboratories. Microorganisms. 2021;9(7): 1539. https:\/\/doi.org\/10.3390\/microorganisms9071539.","journal-title":"Microorganisms"},{"issue":"3","key":"3368_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/09273948.2019.1583346","volume":"28","author":"S Xu","year":"2020","unstructured":"Xu S, Zhou C, Zhang P, Feng C, Zhang T, Sun Z, et al. Diagnostic performance of MALDI-TOF MS compared to conventional microbiological cultures in patients with suspected endophthalmitis. Ocul Immunol and Inflamm. 2020;28(3):483\u201390. https:\/\/doi.org\/10.1080\/09273948.2019.1583346.","journal-title":"Ocul Immunol and Inflamm"},{"issue":"9","key":"3368_CR52","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/ICO.0000000000003315","volume":"42","author":"B Bagga","year":"2023","unstructured":"Bagga B, Das S, Tawde Y, Singh S, Shaw T, Sharma S, et al. Fusarium keratitis from a comprehensive eye health care facility in South India: molecular characterization by MALDI-TOF versus polymerase chain reaction sequencing, species complex distribution, and clinical correlation. Cornea. 2023;42(9):1150\u201362. https:\/\/doi.org\/10.1097\/ICO.0000000000003315.","journal-title":"Cornea"},{"issue":"3","key":"3368_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12281-015-0225-2","volume":"9","author":"AD Van Diepeningen","year":"2015","unstructured":"Van Diepeningen AD, Brankovics B, Iltes J, Van der Lee TA, Waalwijk C. Diagnosis of Fusarium infections: approaches to identification by the clinical mycology laboratory. Curr Fungal Infect Rep. 2015;9(3):135\u201343. https:\/\/doi.org\/10.1007\/s12281-015-0225-2.","journal-title":"Curr Fungal Infect Rep"},{"issue":"8","key":"3368_CR54","volume":"64","author":"S Narendran","year":"2023","unstructured":"Narendran S, Deivarajan HR, Lalitha P, Prajna V. Development and clinical validation of a novel CRISPR-based diagnostic platform for the diagnosis of ocular fungal infections. Invest Ophthalmol Vis Sci. 2023;64(8): 611.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3368_CR55","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.oret.2024.11.003","volume":"9","author":"HR Deivarajan","year":"2025","unstructured":"Deivarajan HR, Elamurugan V, Chelliah D, Gr EN, Nandhakumar D, Sevugamurthi K, et al. Clinical evaluation of a novel CRISPR-Cas12a-based RID-MyC assay for the diagnosis of fungal endophthalmitis. Ophthalmol Retina. 2025;9(5):444\u201352. https:\/\/doi.org\/10.1016\/j.oret.2024.11.003.","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"3368_CR56","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.xops.2024.100522","volume":"4","author":"HR Deivarajan","year":"2024","unstructured":"Deivarajan HR, Elamurugan V, Sivashanmugam P, Pandian J, Sevugamurthi K, Rameshkumar G, et al. Development and clinical evaluation of a CRISPR\/Cas12a-based nucleic acid detection platform for the diagnosis of keratomycoses. Ophthalmol Sci. 2024;4(5):100522. https:\/\/doi.org\/10.1016\/j.xops.2024.100522.","journal-title":"Ophthalmol Sci"},{"issue":"7","key":"3368_CR57","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","volume":"5","author":"MM Kaminski","year":"2021","unstructured":"Kaminski MM, Abudayyeh OO, Gootenberg JS, Zhang F, Collins JJ. CRISPR-based diagnostics. Nat Biomed Eng. 2021;5(7):643\u201356. https:\/\/doi.org\/10.1038\/s41551-021-00760-7.","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"3368_CR58","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/jof8090955","volume":"8","author":"JJ Hoffman","year":"2022","unstructured":"Hoffman JJ, Yadav R, Sanyam SD, Chaudhary P, Roshan A, Singh SK, et al. Diagnosis of fungal keratitis in low-income countries: evaluation of smear microscopy, culture, and in vivo confocal microscopy in Nepal. J Fungi. 2022;8(9):955. https:\/\/doi.org\/10.3390\/jof8090955.","journal-title":"J Fungi"},{"issue":"2","key":"3368_CR59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/eye.2011.275","volume":"26","author":"S Sharma","year":"2012","unstructured":"Sharma S. Diagnosis of infectious diseases of the eye. Eye. 2012;26(2):177\u201384. https:\/\/doi.org\/10.1038\/eye.2011.275.","journal-title":"Eye"},{"issue":"3","key":"3368_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12030679","volume":"12","author":"C Danielescu","year":"2022","unstructured":"Danielescu C, Stanca HT, Iorga RE, Darabus DM, Potop V. The diagnosis and treatment of fungal endophthalmitis: an update. Diagnostics. 2022;12(3): 679. https:\/\/doi.org\/10.3390\/diagnostics12030679.","journal-title":"Diagnostics"},{"key":"3368_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ajo.2019.11.026","volume":"212","author":"J Kosacki","year":"2020","unstructured":"Kosacki J, Boisset S, Maurin M, Cornut PL, Thuret G, Hubanova R, et al. Specific PCR and quantitative real-time PCR in ocular samples from acute and delayed-onset postoperative endophthalmitis. Am J Ophthalmol. 2020;212:34\u201342. https:\/\/doi.org\/10.1016\/j.ajo.2019.11.026.","journal-title":"Am J Ophthalmol"},{"key":"3368_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.579516","volume":"8","author":"L Trovato","year":"2021","unstructured":"Trovato L, Marino A, Pizzo G, Oliveri S. Case report: molecular diagnosis of fungal keratitis associated with contact lenses caused by Fusarium solani. Front Med. 2021;8: 579516. https:\/\/doi.org\/10.3389\/fmed.2021.579516.","journal-title":"Front Med"},{"issue":"1","key":"3368_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9911979","volume":"2024","author":"XY Pan","year":"2024","unstructured":"Pan XY, Wang M, Xu YD, Wang LN. Application of metagenomic next-generation sequencing in the diagnosis of infectious keratitis. J Ophthalmol. 2024;2024(1): 9911979. https:\/\/doi.org\/10.1155\/2024\/9911979.","journal-title":"J Ophthalmol"},{"key":"3368_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/08820538.2019.1620800","volume":"34","author":"L Ma","year":"2019","unstructured":"Ma L, Jakobiec FA, Dryja TP. A review of next-generation sequencing (NGS): applications to the diagnosis of ocular infectious diseases. Semin Ophthalmol. 2019;34:223\u201331. https:\/\/doi.org\/10.1080\/08820538.2019.1620800.","journal-title":"Semin Ophthalmol"},{"key":"3368_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajo.2017.04.011","volume":"179","author":"A Kheirkhah","year":"2017","unstructured":"Kheirkhah A, Syed ZA, Satitpitakul V, Goyal S, M\u00fcller R, Tu EY, et al. Sensitivity and specificity of laser-scanning in vivo confocal microscopy for filamentous fungal keratitis: role of observer experience. Am J Ophthalmol. 2017;179:81\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2017.04.011.","journal-title":"Am J Ophthalmol"},{"key":"3368_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mimet.2014.12.014","volume":"109","author":"A Panda","year":"2015","unstructured":"Panda A, Ghosh AK, Mirdha BR, Xess I, Paul S, Samantaray JC, Srinivasan A, Khalil S, Rastogi N, Dabas Y. MALDI-TOF mass spectrometry for rapid identification of clinical fungal isolates based on ribosomal protein biomarkers. J Microbiol Methods. 2015;109:93\u2013105. https:\/\/doi.org\/10.1016\/j.mimet.2014.12.014.","journal-title":"J Microbiol Methods"},{"issue":"15","key":"3368_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153631","volume":"20","author":"MT Kuo","year":"2019","unstructured":"Kuo MT, Chen JL, Hsu SL, Chen A, You HL. An omics approach to diagnosing or investigating fungal keratitis. Int J Mol Sci. 2019;20(15): 3631. https:\/\/doi.org\/10.3390\/ijms20153631.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3368_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20153631","volume":"12","author":"A Ghouneimy","year":"2022","unstructured":"Ghouneimy A, Mahas A, Marsic T, Aman R, Mahfouz M. CRISPR-based diagnostics: challenges and potential solutions toward point-of-care applications. ACS Synth Biol. 2022;12(1):1\u20136. https:\/\/doi.org\/10.3390\/ijms20153631.","journal-title":"ACS Synth Biol"},{"issue":"10","key":"3368_CR69","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/14787210.2023.2257895","volume":"21","author":"A Chakrabarti","year":"2023","unstructured":"Chakrabarti A, Patel AK, Soman R, Todi S. Overcoming clinical challenges in the management of invasive fungal infections in low-and middle-income countries (LMIC). Expert Rev Anti-Infect Ther. 2023;21(10):1057\u201370. https:\/\/doi.org\/10.1080\/14787210.2023.2257895.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"5","key":"3368_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/jop.2008.0031","volume":"24","author":"IP Kaur","year":"2008","unstructured":"Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther. 2008;24(5):481\u201394. https:\/\/doi.org\/10.1089\/jop.2008.0031.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3368_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12281-019-00338-6","volume":"13","author":"R Thakkar","year":"2019","unstructured":"Thakkar R, Patil A, Mehraj T, Dudhipala N, Majumdar S. Updates in ocular antifungal pharmacotherapy: formulation and clinical perspectives. Curr Fungal Infect Rep. 2019;13:45\u201358. https:\/\/doi.org\/10.1007\/s12281-019-00338-6.","journal-title":"Curr Fungal Infect Rep"},{"key":"3368_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120924","volume":"607","author":"M Mofidfar","year":"2021","unstructured":"Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, et al. Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm. 2021;607: 120924. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120924.","journal-title":"Int J Pharm"},{"issue":"11","key":"3368_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111201","volume":"14","author":"B Gupta","year":"2021","unstructured":"Gupta B, Mishra V, Gharat S, Momin M, Omri A. Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems. Pharmaceuticals. 2021;14(11): 1201. https:\/\/doi.org\/10.3390\/ph14111201.","journal-title":"Pharmaceuticals"},{"issue":"7","key":"3368_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/jof7070511","volume":"7","author":"G Walther","year":"2021","unstructured":"Walther G, Zimmermann A, Theuersbacher J, Kaerger K, von Lilienfeld-Toal M, Roth M, et al. Eye infections caused by filamentous fungi: spectrum and antifungal susceptibility of the prevailing agents in Germany. J Fungi. 2021;7(7): 511. https:\/\/doi.org\/10.3390\/jof7070511.","journal-title":"J Fungi"},{"issue":"3","key":"3368_CR75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/08820538.2022.2095873","volume":"38","author":"K Deogaonkar","year":"2023","unstructured":"Deogaonkar K, Roy A. Donor-related corneal graft infection: a review of literature and preventive strategies. Semin Ophthalmol. 2023;38(3):219\u201325. https:\/\/doi.org\/10.1080\/08820538.2022.2095873.","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"3368_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061746","volume":"15","author":"M Mostafa","year":"2023","unstructured":"Mostafa M, Al Fatease A, Alany RG, Abdelkader H. Recent advances of ocular drug delivery systems: prominence of ocular implants for chronic eye diseases. Pharmaceutics. 2023;15(6): 1746. https:\/\/doi.org\/10.3390\/pharmaceutics15061746.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3368_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020625","volume":"15","author":"L Pelusi","year":"2023","unstructured":"Pelusi L, Mandatori D, Mastropasqua L, Agnifili L, Allegretti M, Nubile M, et al. Innovation in the development of synthetic and natural ocular drug delivery systems for eye diseases treatment: focusing on drug-loaded ocular inserts, contacts, and intraocular lenses. Pharmaceutics. 2023;15(2): 625. https:\/\/doi.org\/10.3390\/pharmaceutics15020625.","journal-title":"Pharmaceutics"},{"key":"3368_CR78","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S268208","author":"GA El-Emam","year":"2020","unstructured":"El-Emam GA, Girgis GN, El-Sokkary MM, El-Azeem Soliman OA, Abd El Gawad AE. Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S268208.","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"3368_CR79","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s13346-024-01527-8","volume":"14","author":"HE Teba","year":"2024","unstructured":"Teba HE, Khalil IA, Gebreel RM, Fahmy LI, Sorogy HM. Development of antifungal fibrous ocular insert using freeze-drying technique. Drug Deliv Transl Res. 2024;14(9):2520\u201338. https:\/\/doi.org\/10.1007\/s13346-024-01527-8.","journal-title":"Drug Deliv Transl Res"},{"key":"3368_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114342","volume":"187","author":"RA Alshaikh","year":"2022","unstructured":"Alshaikh RA, Waeber C, Ryan KB. Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies. Adv Drug Deliv Rev. 2022;187: 114342. https:\/\/doi.org\/10.1016\/j.addr.2022.114342.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"3368_CR81","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.drudis.2019.05.031","volume":"24","author":"Y Cao","year":"2019","unstructured":"Cao Y, Samy KE, Bernards DA, Desai TA. Recent advances in intraocular sustained-release drug delivery devices. Drug Discov Today. 2019;24(8):1694\u2013700. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.031.","journal-title":"Drug Discov Today"},{"key":"3368_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125822","author":"C Johnson","year":"2025","unstructured":"Johnson C, Chen B, Bhalla A, Crowell E, Zhang F. Elimination of \u201clag\u201d and \u201cburst\u201d phases in drug release profiles of melt-extruded, PLGA-based intravitreal implants. Int J Pharm. 2025. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125822.","journal-title":"Int J Pharm"},{"issue":"10","key":"3368_CR83","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/17425247.2022.2108397","volume":"19","author":"MN O\u2019Brien Laramy","year":"2022","unstructured":"O\u2019Brien Laramy MN, Nagapudi K. Long-acting ocular drug delivery technologies with clinical precedent. Expert Opin Drug Deliv. 2022;19(10):1285\u2013301. https:\/\/doi.org\/10.1080\/17425247.2022.2108397.","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"3368_CR84","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s10792-023-02637-x","volume":"43","author":"YY Cong","year":"2023","unstructured":"Cong YY, Fan B, Zhang ZY, Li GY. Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics. Int Ophthalmol. 2023;43(7):2575\u201388. https:\/\/doi.org\/10.1007\/s10792-023-02637-x.","journal-title":"Int Ophthalmol"},{"issue":"15","key":"3368_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ma14154290","volume":"14","author":"M Koutsoviti","year":"2021","unstructured":"Koutsoviti M, Siamidi A, Pavlou P, Vlachou M. Recent advances in the excipients used for modified ocular drug delivery. Materials. 2021;14(15): 4290. https:\/\/doi.org\/10.3390\/ma14154290.","journal-title":"Materials"},{"issue":"3","key":"3368_CR86","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s13346-020-00825-1","volume":"11","author":"HG Wafa","year":"2021","unstructured":"Wafa HG, Essa EA, El-Sisi AE, El Maghraby GM. Ocular films versus film-forming liquid systems for enhanced ocular drug delivery. Drug Deliv Transl Res. 2021;11(3):1084\u201395. https:\/\/doi.org\/10.1007\/s13346-020-00825-1.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3368_CR87","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1021\/acs.molpharmaceut.1c00746","volume":"19","author":"P Suvarna","year":"2021","unstructured":"Suvarna P, Chaudhari P, Birangal S, Mallela LS, Roy S, Koteshwara A, et al. Voriconazole\u2013cyclodextrin supramolecular ternary complex-loaded ocular films for management of fungal keratitis. Mol Pharm. 2021;19(1):258\u201373. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00746.","journal-title":"Mol Pharm"},{"issue":"11","key":"3368_CR88","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/jof10110762","volume":"10","author":"C Rapti","year":"2024","unstructured":"Rapti C, Luciano FC, Anaya BJ, Ramirez BI, Ongoren B, Dea-Ayuela MA, et al. Amphotericin B ocular films for fungal keratitis and a novel 3d-printed microfluidic ocular lens infection model. J Fungi. 2024;10(11):762. https:\/\/doi.org\/10.3390\/jof10110762.","journal-title":"J Fungi"},{"issue":"3","key":"3368_CR89","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","volume":"7","author":"Y Weng","year":"2017","unstructured":"Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 2017;7(3):281\u201391. https:\/\/doi.org\/10.1016\/j.apsb.2016.09.001.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"3368_CR90","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1007\/s12668-024-01447-4","volume":"14","author":"H Mehendiratta","year":"2024","unstructured":"Mehendiratta H, Singh S, Sharma N, Kishore L, Dwivedi M, Rani A. Advances in liposomes-based therapeutics as cutting-edge for ocular fungal infections: an updated review. BioNanoSci. 2024;14(3):3522\u201335. https:\/\/doi.org\/10.1007\/s12668-024-01447-4.","journal-title":"BioNanoSci"},{"key":"3368_CR91","doi-asserted-by":"publisher","first-page":"103517","DOI":"10.1016\/j.jddst.2022.103517","volume":"74","author":"SN Sanap","year":"2022","unstructured":"Sanap SN, Bisen AC, Mishra A, Biswas A, Agrawal S, Yadav KS, et al. QbD-based antifungal drug-loaded ophthalmic liposomal formulation for the management of fungal keratitis: in vitro, ex vivo and in vivo pharmacokinetic studies. J Drug Deliv Sci Technol. 2022;74:103517. https:\/\/doi.org\/10.1016\/j.jddst.2022.103517.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"3368_CR92","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/20415990.2024.2379756","volume":"15","author":"M Macwan","year":"2024","unstructured":"Macwan M, Paliwal H, Prajapati BG. A novel liposomal formulation for ocular delivery of caspofungin: an experimental study by quality by design-based approach. Ther Deliv. 2024;15(9):667\u201383. https:\/\/doi.org\/10.1080\/20415990.2024.2379756.","journal-title":"Ther Deliv"},{"key":"3368_CR93","doi-asserted-by":"publisher","first-page":"101944","DOI":"10.1016\/j.jddst.2020.101944","volume":"60","author":"A Mishra","year":"2020","unstructured":"Mishra A, Bano M, Bisen AC, Verma S, Sanap SN, Kishor R, et al. Topical corneal targeted sustained release amphotericin B liposomal formulation for the treatment of fungal keratitis and its PK-PD evaluation. J Drug Deliv Sci Technol. 2020;60:101944. https:\/\/doi.org\/10.1016\/j.jddst.2020.101944.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"3368_CR94","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijpharm.2017.10.007","volume":"534","author":"MA Moustafa","year":"2017","unstructured":"Moustafa MA, Elnaggar YS, El-Refaie WM, Abdallah OY. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect. Int J Pharm. 2017;534(1\u20132):14\u201324. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.10.007.","journal-title":"Int J Pharm"},{"issue":"3","key":"3368_CR95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11046-014-9837-2","volume":"179","author":"AFG Leal","year":"2015","unstructured":"Leal AFG, Leite MC, Medeiros CSQ, et al. Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis. Mycopathologia. 2015;179(3):225\u20139. https:\/\/doi.org\/10.1007\/s11046-014-9837-2.","journal-title":"Mycopathologia"},{"key":"3368_CR96","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.colsurfb.2015.06.036","volume":"133","author":"FA de S\u00e1","year":"2015","unstructured":"de S\u00e1 FA, Taveira SF, Gelfuso GM, Lima EM, Gratieri T. Liposomal voriconazole (VOR) formulation for improved ocular delivery. Colloids Surf B Biointerfaces. 2015;133:331\u20138. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.06.036.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"3368_CR97","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/nano10061191","volume":"10","author":"S Durak","year":"2020","unstructured":"Durak S, Esmaeili Rad M, Alp Yetisgin A, Sutova HE, Kutlu O, Cetinel S, et al. Niosomal drug delivery systems for ocular disease\u2014recent advances and future prospects. Nanomaterials. 2020;10(6):1191. https:\/\/doi.org\/10.3390\/nano10061191.","journal-title":"Nanomaterials"},{"key":"3368_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106219","author":"AL Onugwu","year":"2024","unstructured":"Onugwu AL, Emencheta SC, Sabastine RN, Onugwu SO, Echezona AC, Nwagwu CS, et al. Review of nanoformulations for treating ocular fungal infections. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.106219.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"3368_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-024-09850-w","volume":"19","author":"GE Yassin","year":"2024","unstructured":"Yassin GE, Amer MA, Mannaa IM, et al. Fluconazole-niosome-laden contact lens: a promising therapeutic approach for prolonged ocular delivery and enhanced antifungal activity. J Pharm Innov. 2024;19(4): 45. https:\/\/doi.org\/10.1007\/s12247-024-09850-w.","journal-title":"J Pharm Innov"},{"key":"3368_CR100","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.ijpx.2025.100322","volume":"9","author":"S Ahmed","year":"2025","unstructured":"Ahmed S, Farag MM, Attia H, Balkhi B, Adel IM, Nemr AA. Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: a comprehensive investigation from laboratory characterization to microbiological evaluation. Int J Pharm X. 2025;9:100322. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100322.","journal-title":"Int J Pharm X"},{"issue":"12","key":"3368_CR101","doi-asserted-by":"publisher","first-page":"102208","DOI":"10.1016\/j.jsps.2024.102208","volume":"32","author":"MM Badran","year":"2024","unstructured":"Badran MM, Alsubaie A, Bekhit MM, Alomrani AH, Almomen A, Ibrahim MA, et al. Bioadhesive hybrid system of niosomes and pH sensitive in situ gel for itraconazole ocular delivery: dual approach for efficient treatment of fungal infections. Saudi Pharm J. 2024;32(12):102208. https:\/\/doi.org\/10.1016\/j.jsps.2024.102208.","journal-title":"Saudi Pharm J"},{"key":"3368_CR102","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jddst.2016.06.002","volume":"35","author":"G Fetih","year":"2016","unstructured":"Fetih G. Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections. J Drug Deliv Sci Technol. 2016;35:8\u201315. https:\/\/doi.org\/10.1016\/j.jddst.2016.06.002.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"3368_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ph16071001","volume":"16","author":"SD Satyanarayana","year":"2023","unstructured":"Satyanarayana SD, Abu Lila AS, Moin A, Moglad EH, Khafagy ES, Alotaibi HF, et al. Ocular delivery of bimatoprost-loaded solid lipid nanoparticles for effective management of glaucoma. Pharmaceuticals. 2023;16(7): 1001. https:\/\/doi.org\/10.3390\/ph16071001.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"3368_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030474","volume":"16","author":"V Gugleva","year":"2023","unstructured":"Gugleva V, Andonova V. Recent progress of solid lipid nanoparticles and nanostructured lipid carriers as ocular drug delivery platforms. Pharmaceuticals. 2023;16(3): 474. https:\/\/doi.org\/10.3390\/ph16030474.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"3368_CR105","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/10837450.2014.882935","volume":"20","author":"B Mohanty","year":"2015","unstructured":"Mohanty B, Majumdar DK, Mishra SK, Panda AK, Patnaik S. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm Dev Technol. 2015;20(4):458\u201364. https:\/\/doi.org\/10.3109\/10837450.2014.882935.","journal-title":"Pharm Dev Technol"},{"key":"3368_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106494","volume":"187","author":"Z Liang","year":"2023","unstructured":"Liang Z, Zhang Z, Lu P, Yang J, Han L, Liu S, et al. The effect of charges on the corneal penetration of solid lipid nanoparticles loaded Econazole after topical administration in rabbits. Eur J Pharm Sci. 2023;187: 106494. https:\/\/doi.org\/10.1016\/j.ejps.2023.106494.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3368_CR107","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/11206721231174653","volume":"34","author":"F Zhang","year":"2024","unstructured":"Zhang F, Zhang J, Zhang W. Recent advances in nanotechnology for the treatment of fungal keratitis. Eur J Ophthalmol. 2024;34(1):18\u201329. https:\/\/doi.org\/10.1177\/11206721231174653.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"3368_CR108","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/08982104.2016.1224899","volume":"27","author":"T Fu","year":"2017","unstructured":"Fu T, Yi J, Lv S, Zhang B. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy. J Liposome Res. 2017;27(3):228\u201333. https:\/\/doi.org\/10.1080\/08982104.2016.1224899.","journal-title":"J Liposome Res"},{"issue":"7","key":"3368_CR109","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/10837450.2019.1616755","volume":"24","author":"N Tavakoli","year":"2019","unstructured":"Tavakoli N, Taymouri S, Saeidi A, Akbari V. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis. Pharm Dev Technol. 2019;24(7):891\u2013901. https:\/\/doi.org\/10.1080\/10837450.2019.1616755.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"3368_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sjbs.2021.11.006","volume":"29","author":"M Kumar","year":"2022","unstructured":"Kumar M, Tiwari A, Asdaq SM, Nair AB, Bhatt S, Shinu P, et al. Itraconazole loaded nanostructured lipid carrier for topical ocular delivery: optimization and evaluation. Saudi J Biol Sci. 2022;29(1):1\u201310. https:\/\/doi.org\/10.1016\/j.sjbs.2021.11.006.","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"3368_CR111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10837450.2025.2488999","volume":"30","author":"TA Samra","year":"2025","unstructured":"Samra TA, Elbahwy IA, Mowafy HA, Afouna MI. Enhancing ocular drug delivery: development and in vivo evaluation of mucoadhesive nanostructured lipid carriers for terbinafine. Pharm Dev Technol. 2025;30(4):417\u201329. https:\/\/doi.org\/10.1080\/10837450.2025.2488999.","journal-title":"Pharm Dev Technol"},{"key":"3368_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118771","volume":"572","author":"P Lakhani","year":"2019","unstructured":"Lakhani P, Patil A, Wu KW, Sweeney C, Tripathi S, Avula B, et al. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019;572: 118771. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118771.","journal-title":"Int J Pharm"},{"issue":"3","key":"3368_CR113","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/1574885518666230804120659","volume":"19","author":"MM Mahboobian","year":"2024","unstructured":"Mahboobian MM, Azadi N, Pourmoslemi S. Preparation of ketoconazole-loaded nanoemulsions for ophthalmic delivery: characterization and in vitro antifungal activity evaluation. Curr Drug Ther. 2024;19(3):327\u201335. https:\/\/doi.org\/10.2174\/1574885518666230804120659.","journal-title":"Curr Drug Ther"},{"issue":"10","key":"3368_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102052","volume":"14","author":"J Yang","year":"2022","unstructured":"Yang J, Liang Z, Lu P, Song F, Zhang Z, Zhou T, et al. Development of a luliconazole nanoemulsion as a prospective ophthalmic delivery system for the treatment of fungal keratitis: in vitro and in vivo evaluation. Pharmaceutics. 2022;14(10): 205. https:\/\/doi.org\/10.3390\/pharmaceutics14102052.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3368_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25258\/ijddt.11.3.00","volume":"11","author":"ST Nasser","year":"2021","unstructured":"Nasser ST, Abdulrassol AA, Ghareeb MM. Design, preparation and in-vitro evaluation of novel ocular antifungal nanoemulsion using posaconazole as a model drug. Int J Drug Deliv Technol. 2021;11(3):1\u20137. https:\/\/doi.org\/10.25258\/ijddt.11.3.00.","journal-title":"Int J Drug Deliv Technol"},{"issue":"1","key":"3368_CR116","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01900-z","volume":"22","author":"A Verma","year":"2021","unstructured":"Verma A, Jain A, Tiwari A, Saraf S, Panda PK, Jain SK. Promising antifungal potential of engineered non-ionic surfactant-based vesicles: in vitro and in vivo studies. AAPS PharmSciTech. 2021;22(1): 19. https:\/\/doi.org\/10.1208\/s12249-020-01900-z.","journal-title":"AAPS PharmSciTech"},{"key":"3368_CR117","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S340068","author":"Z Liang","year":"2021","unstructured":"Liang Z, Zhang Z, Yang J, Lu P, Zhou T, Li J, Zhang J. Assessment to the antifungal effects in vitro and the ocular pharmacokinetics of solid-lipid nanoparticle in rabbits. Int J Nanomedicine. 2021. https:\/\/doi.org\/10.2147\/IJN.S340068.","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"3368_CR118","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1080\/03639045.2016.1185437","volume":"42","author":"R Kumar","year":"2016","unstructured":"Kumar R, Sinha VR. Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole. Drug Dev Ind Pharm. 2016;42(12):1956\u201367. https:\/\/doi.org\/10.1080\/03639045.2016.1185437.","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"3368_CR119","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/15376516.2021.1941461","volume":"31","author":"M Tavakoli","year":"2021","unstructured":"Tavakoli M, Mahboobian MM, Nouri F, Mohammadi M. Studying the ophthalmic toxicity potential of developed ketoconazole loaded nanoemulsion in situ gel formulation for ophthalmic administration. Toxicol Mech Methods. 2021;31(8):572\u201380. https:\/\/doi.org\/10.1080\/15376516.2021.1941461.","journal-title":"Toxicol Mech Methods"},{"issue":"23","key":"3368_CR120","doi-asserted-by":"publisher","first-page":"20267","DOI":"10.1021\/acsomega.2c02219","volume":"7","author":"M Shahid","year":"2022","unstructured":"Shahid M, Hussain A, Khan AA, Ramzan M, Alaofi AL, Alanazi AM, et al. Ketoconazole-loaded cationic nanoemulsion: in vitro\u2013ex vivo\u2013in vivo evaluations to control cutaneous fungal infections. ACS Omega. 2022;7(23):20267\u201379. https:\/\/doi.org\/10.1021\/acsomega.2c02219.","journal-title":"ACS Omega"},{"issue":"1","key":"3368_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12668-024-01631-6","volume":"15","author":"U Gohil","year":"2025","unstructured":"Gohil U, Chandarana C, Prajapati P, Prajapati B. Polymeric nanoparticles in ophthalmology: a comprehensive review of therapeutic applications. BioNanoSci. 2025;15(1):1\u20139. https:\/\/doi.org\/10.1007\/s12668-024-01631-6.","journal-title":"BioNanoSci"},{"key":"3368_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023;196: 114770. https:\/\/doi.org\/10.1016\/j.addr.2023.114770.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"3368_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092830","volume":"19","author":"CH Tsai","year":"2018","unstructured":"Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci. 2018;19(9): 2830. https:\/\/doi.org\/10.3390\/ijms19092830.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3368_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/polym15010209","volume":"15","author":"AM Almehmady","year":"2022","unstructured":"Almehmady AM, El-Say KM, Mubarak MA, Alghamdi HA, Somali NA, Sirwi A, et al. Enhancing the antifungal activity and ophthalmic transport of fluconazole from PEGylated polycaprolactone loaded nanoparticles. Polymers. 2022;15(1): 209. https:\/\/doi.org\/10.3390\/polym15010209.","journal-title":"Polymers"},{"issue":"1","key":"3368_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11010073","volume":"11","author":"A Alakkad","year":"2022","unstructured":"Alakkad A, Stapleton P, Schlosser C, Murdan S, Odunze U, Schatzlein A, et al. Amphotericin B polymer nanoparticles show efficacy against Candida species biofilms. Pathogens. 2022;11(1): 73. https:\/\/doi.org\/10.3390\/pathogens11010073.","journal-title":"Pathogens"},{"key":"3368_CR126","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2147\/IJN.S332127","volume":"17","author":"X Sha","year":"2022","unstructured":"Sha X, Chan L, Fan X, Guo P, Chen T, Liu L, et al. Thermosensitive tri-block polymer nanoparticle-hydrogel composites as payloads of natamycin for antifungal therapy against Fusarium solani. Int J Nanomedicine. 2022;17:1463\u201378. https:\/\/doi.org\/10.2147\/IJN.S332127.","journal-title":"Int J Nanomedicine"},{"key":"3368_CR127","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2147\/IJN.S131850.","volume":"12","author":"TA Ahmed","year":"2017","unstructured":"Ahmed TA, Aljaeid BM. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. Int J Nanomedicine. 2017;12:1863\u201375. https:\/\/doi.org\/10.2147\/IJN.S131850.","journal-title":"Int J Nanomedicine"},{"issue":"44","key":"3368_CR128","doi-asserted-by":"publisher","first-page":"59777","DOI":"10.1021\/acsami.4c11366.","volume":"16","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang Y, Peng F, Li C, Wang Q, Wang Z, et al. Macrophage membrane-coated nanoparticles for the delivery of natamycin exhibit increased antifungal and anti-inflammatory activities in fungal keratitis. ACS Appl Mater Interfaces. 2024;16(44):59777\u201388. https:\/\/doi.org\/10.1021\/acsami.4c11366.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"3368_CR129","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17425247.2020.1719995.","volume":"17","author":"Y Guo","year":"2020","unstructured":"Guo Y, Karimi F, Fu Q, Qiao GG, Zhang H. Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution. Expert Opin Drug Deliv. 2020;17(3):407\u201321. https:\/\/doi.org\/10.1080\/17425247.2020.1719995.","journal-title":"Expert Opin Drug Deliv"},{"key":"3368_CR130","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.colsurfb.2015.03.059.","volume":"130","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Kumar M, Pathak K. Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis. Colloids Surf B Biointerfaces. 2015;130:23\u201330. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.03.059.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3368_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106629.","volume":"192","author":"P Lu","year":"2024","unstructured":"Lu P, Liang Z, Zhang Z, Yang J, Song F, Zhou T, et al. Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: in vitro and in vivo study. Eur J Pharm Sci. 2024;192: 106629. https:\/\/doi.org\/10.1016\/j.ejps.2023.106629.","journal-title":"Eur J Pharm Sci"},{"key":"3368_CR132","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bioactmat.2025.04.011.","volume":"50","author":"M Cai","year":"2025","unstructured":"Cai M, Zhong H, Wang X, Li L, Zhou X, Wang Y, et al. Pathology-inspired collagen-binding thermosensitive micelle drops enable prolonged and efficient treatment of fungal keratitis. Bioact Mater. 2025;50:396\u2013413. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.04.011.","journal-title":"Bioact Mater"},{"key":"3368_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S93069","volume":"11","author":"M Kalomiraki","year":"2016","unstructured":"Kalomiraki M, Thermos K, Chaniotakis NA. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomedicine. 2016;11:1\u20132. https:\/\/doi.org\/10.2147\/IJN.S93069.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3368_CR134","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijpharm.2016.07.031","volume":"511","author":"JR Villanueva","year":"2016","unstructured":"Villanueva JR, Navarro MG, Villanueva LR. Dendrimers as a promising tool in ocular therapeutics: latest advances and perspectives. Int J Pharm. 2016;511(1):359\u201366. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.031.","journal-title":"Int J Pharm"},{"issue":"6","key":"3368_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061591","volume":"15","author":"A Dhull","year":"2023","unstructured":"Dhull A, Yu C, Wilmoth AH, Chen M, Sharma A, Yiu S. Dendrimers in corneal drug delivery: recent developments and translational opportunities. Pharmaceutics. 2023;15(6): 1591. https:\/\/doi.org\/10.3390\/pharmaceutics15061591.","journal-title":"Pharmaceutics"},{"issue":"7","key":"3368_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071952","volume":"15","author":"KY Wu","year":"2023","unstructured":"Wu KY, Tan K, Akbar D, Choulakian MY, Tran SD. A new era in ocular therapeutics: advanced drug delivery systems for uveitis and neuro-ophthalmologic conditions. Pharmaceutics. 2023;15(7): 1952. https:\/\/doi.org\/10.3390\/pharmaceutics15071952.","journal-title":"Pharmaceutics"},{"key":"3368_CR137","doi-asserted-by":"publisher","first-page":"103327","DOI":"10.1016\/j.jddst.2022.103327","volume":"71","author":"P Chaudhari","year":"2022","unstructured":"Chaudhari P, Shetty D, Lewis SA. Recent progress in colloidal nanocarriers loaded in situ gel in ocular therapeutics. J Drug Deliv Sci Technol. 2022;71:103327. https:\/\/doi.org\/10.1016\/j.jddst.2022.103327.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3368_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/polym16010148","volume":"16","author":"P Chomchalao","year":"2024","unstructured":"Chomchalao P, Saelim N, Lamlertthon S, Sisopa P, Tiyaboonchai W. Mucoadhesive hybrid system of silk fibroin nanoparticles and thermosensitive in situ hydrogel for amphotericin B delivery: a potential option for fungal keratitis treatment. Polymers. 2024;16(1): 148. https:\/\/doi.org\/10.3390\/polym16010148.","journal-title":"Polymers"},{"key":"3368_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120623","volume":"602","author":"AD Permana","year":"2021","unstructured":"Permana AD, Utami RN, Layadi P, Himawan A, Juniarti N, Anjani QK, et al. Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis. Int J Pharm. 2021;602: 120623. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120623.","journal-title":"Int J Pharm"},{"key":"3368_CR140","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jddst.2018.12.005","volume":"49","author":"N\u00dc Okur","year":"2019","unstructured":"Okur N\u00dc, Yozgatl\u0131 V, Okur ME, Yolta\u015f A, Siafaka PI. Improving therapeutic efficacy of voriconazole against fungal keratitis: thermo-sensitive in situ gels as ophthalmic drug carriers. J Drug Deliv Sci Technol. 2019;49:323\u201333. https:\/\/doi.org\/10.1016\/j.jddst.2018.12.005.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3368_CR141","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","volume":"72","author":"YS Chhonker","year":"2015","unstructured":"Chhonker YS, Prasad YD, Chandasana H, Vishvkarma A, Mitra K, Shukla PK, et al. Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol. 2015;72:1451\u20138. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.10.014.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3368_CR142","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.xphs.2021.09.019","volume":"111","author":"AM Mohsen","year":"2022","unstructured":"Mohsen AM. Cationic polymeric nanoparticles for improved ocular delivery and antimycotic activity of terconazole. J Pharm Sci. 2022;111(2):458\u201368. https:\/\/doi.org\/10.1016\/j.xphs.2021.09.019.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3368_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/gels11010013","volume":"11","author":"C Chaiwut","year":"2024","unstructured":"Chaiwut C, Tadtong S, Akachaipaibul P, Jiaranaikulwanitch J, Singh S, Okonogi S, et al. Thermosensitive in situ ophthalmic gel for effective local delivery and antifungal activity of ketoconazole nanoparticles. Gels. 2024;11(1): 13. https:\/\/doi.org\/10.3390\/gels11010013.","journal-title":"Gels"},{"issue":"1","key":"3368_CR144","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-024-09915-w","volume":"20","author":"D Nunse","year":"2025","unstructured":"Nunse D, Shevalkar GB, Borse L. Innovative polymeric micelles with in-situ gelation for enhanced ocular delivery of ketoconazole. J Pharm Innov. 2025;20(1): 2. https:\/\/doi.org\/10.1007\/s12247-024-09915-w.","journal-title":"J Pharm Innov"},{"issue":"15","key":"3368_CR145","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1039\/D1TB00263E","volume":"9","author":"F Wang","year":"2021","unstructured":"Wang F, Zhao L, Song F, Wu J, Zhou Q, Xie L. Hybrid natural hydrogels integrated with voriconazole-loaded microspheres for ocular antifungal applications. J Mater Chem. 2021;9(15):3377\u201388. https:\/\/doi.org\/10.1039\/D1TB00263E.","journal-title":"J Mater Chem"},{"key":"3368_CR146","doi-asserted-by":"publisher","unstructured":"Vieira IR, Tessaro L, Conte-Junior CA (2024) Gold nanoparticles for treatment of infectious diseases. In: Gold nanoparticles for drug delivery. Cambridge, MA: Academic Press p. 277\u2013303. https:\/\/doi.org\/10.1016\/B978-0-443-19061-2.00004-3.","DOI":"10.1016\/B978-0-443-19061-2.00004-3"},{"issue":"11","key":"3368_CR147","doi-asserted-by":"publisher","first-page":"17582","DOI":"10.1021\/acsnano.1c05002","volume":"15","author":"US Kumar","year":"2021","unstructured":"Kumar US, Afjei R, Ferrara K, Massoud TF, Paulmurugan R. Gold-nanostar-chitosan-mediated delivery of SARS-CoV-2 DNA vaccine for respiratory mucosal immunization: development and proof-of-principle. ACS Nano. 2021;15(11):17582\u2013601. https:\/\/doi.org\/10.1021\/acsnano.1c05002.","journal-title":"ACS Nano"},{"issue":"4","key":"3368_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040505","volume":"10","author":"A Sengupta","year":"2022","unstructured":"Sengupta A, Azharuddin M, Al-Otaibi N, Hinkula J. Efficacy and immune response elicited by gold nanoparticle-based nanovaccines against infectious diseases. Vaccines. 2022;10(4): 505. https:\/\/doi.org\/10.3390\/vaccines10040505.","journal-title":"Vaccines"},{"key":"3368_CR149","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/DDDT.S91730","volume":"10","author":"HF Salem","year":"2016","unstructured":"Salem HF, Ahmed SM, Omar MM. Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery. Drug Des Devel Ther. 2016;10:277\u201395. https:\/\/doi.org\/10.2147\/DDDT.S91730.","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"3368_CR150","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/jop.2023.0004","volume":"39","author":"DF Ghoniem","year":"2023","unstructured":"Ghoniem DF, Abdelkawi SA, Fadel M, Abdel Fadeel D, Fouly M, El-Kholy AI, et al. Novel photodynamic\/photothermal treatment of fungal keratitis using rose bengal-loaded polypyrrole-gold nanoparticles in Wistar albino rats. J Ocul Pharmacol Ther. 2023;39(6):379\u201388. https:\/\/doi.org\/10.1089\/jop.2023.0004.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"3368_CR151","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/jfb13040242","volume":"13","author":"AH Hashem","year":"2022","unstructured":"Hashem AH, Saied E, Amin BH, Alotibi FO, Al-Askar AA, Arishi AA, et al. Antifungal activity of biosynthesized silver nanoparticles (AgNPs) against aspergilli causing aspergillosis: ultrastructure study. J Funct Biomater. 2022;13(4):242. https:\/\/doi.org\/10.3390\/jfb13040242.","journal-title":"J Funct Biomater"},{"issue":"2","key":"3368_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/coatings13020265","volume":"13","author":"AR Blanco","year":"2023","unstructured":"Blanco AR, Marino A, D\u2019Arrigo M, Nostro A. Activity of colloidal silver solution against microorganisms implicated in ocular infections. Coatings. 2023;13(2): 265. https:\/\/doi.org\/10.3390\/coatings13020265.","journal-title":"Coatings"},{"issue":"5","key":"3368_CR153","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1021\/acsbiomaterials.7b00977","volume":"4","author":"X Liu","year":"2018","unstructured":"Liu X, Chen J, Qu C, Bo G, Jiang L, Zhao H, et al. A mussel-inspired facile method to prepare multilayer-AgNP-loaded contact lens for early treatment of bacterial and fungal keratitis. ACS Biomater Sci Eng. 2018;4(5):1568\u201379. https:\/\/doi.org\/10.1021\/acsbiomaterials.7b00977.","journal-title":"ACS Biomater Sci Eng"},{"key":"3368_CR154","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcis.2021.11.145","volume":"610","author":"L Ma","year":"2022","unstructured":"Ma L, Li K, Xia J, Chen C, Liu Y, Lang S, et al. Commercial soft contact lenses engineered with zwitterionic silver nanoparticles for effectively treating microbial keratitis. J Colloid Interface Sci. 2022;610:923\u201333. https:\/\/doi.org\/10.1016\/j.jcis.2021.11.145.","journal-title":"J Colloid Interface Sci"},{"issue":"12","key":"3368_CR155","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1021\/acsbiomaterials.0c01347","volume":"6","author":"FS Rodrigues","year":"2020","unstructured":"Rodrigues FS, Campos A, Martins J, Ambrosio AF, Campos EJ. Emerging trends in nanomedicine for improving ocular drug delivery: light-responsive nanoparticles, mesoporous silica nanoparticles, and contact lenses. ACS Biomater Sci Eng. 2020;6(12):6587\u201397. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01347.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"3368_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21501203.2023.2285764","volume":"15","author":"X Zhu","year":"2024","unstructured":"Zhu X, Chen Y, Yu D, Fang W, Liao W, Pan W. Progress in the application of nanoparticles for the treatment of fungal infections: a review. Mycology. 2024;15(1):1\u20136. https:\/\/doi.org\/10.1080\/21501203.2023.2285764.","journal-title":"Mycology"},{"issue":"18","key":"3368_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810104","volume":"22","author":"W Du","year":"2021","unstructured":"Du W, Gao Y, Liu L, Sai S, Ding C. Striking back against fungal infections: the utilization of nanosystems for antifungal strategies. Int J Mol Sci. 2021;22(18): 10104. https:\/\/doi.org\/10.3390\/ijms221810104.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3368_CR158","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02969-6","volume":"25","author":"M Mohammadi","year":"2024","unstructured":"Mohammadi M, Rahmani S, Ebrahimi Z, et al. In situ forming hydrogel reinforced with antibiotic-loaded mesoporous silica nanoparticles for the treatment of bacterial keratitis. AAPS PharmSciTech. 2024;25(8): 254. https:\/\/doi.org\/10.1208\/s12249-024-02969-6.","journal-title":"AAPS PharmSciTech"},{"issue":"15","key":"3368_CR159","doi-asserted-by":"publisher","first-page":"18630","DOI":"10.1021\/acsami.2c22860","volume":"15","author":"CF Lai","year":"2023","unstructured":"Lai CF, Shiau FJ. Enhanced and extended ophthalmic drug delivery by pH-triggered drug-eluting contact lenses with large-pore mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2023;15(15):18630\u20138. https:\/\/doi.org\/10.1021\/acsami.2c22860.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3368_CR160","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jphotobiol.2013.07.017","volume":"128","author":"K Kairyte","year":"2013","unstructured":"Kairyte K, Kadys A, Luksiene Z. Antibacterial and antifungal activity of photoactivated ZnO nanoparticles in suspension. J Photochem Photobiol B. 2013;128:78\u201384. https:\/\/doi.org\/10.1016\/j.jphotobiol.2013.07.017.","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"3368_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23577.","volume":"35","author":"S Ahmadpour Kermani","year":"2021","unstructured":"Ahmadpour Kermani S, Salari S, Ghasemi Nejad Almani P. Comparison of antifungal and cytotoxicity activities of titanium dioxide and zinc oxide nanoparticles with amphotericin B against different Candida species: in vitro evaluation. J Clin Lab Anal. 2021;35(1): e23577. https:\/\/doi.org\/10.1002\/jcla.23577.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"3368_CR162","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5281\/zenodo.7317423","volume":"8","author":"RS Mouhamad","year":"2022","unstructured":"Mouhamad RS, Al Khafaji KA, Al-Dharob MH, Al-Abodi EE. Antifungal, antibacterial and anti-yeast activities evaluation of oxides of silver, zinc and titanium nanoparticles. Chem Int. 2022;8(4):159\u201366. https:\/\/doi.org\/10.5281\/zenodo.7317423.","journal-title":"Chem Int"},{"key":"3368_CR163","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.actbio.2021.04.014","volume":"128","author":"SA Khan","year":"2021","unstructured":"Khan SA, Shahid S, Mahmood T, Lee CS. Contact lenses coated with hybrid multifunctional ternary nanocoatings (phytomolecule-coated ZnO nanoparticles: gallic acid: tobramycin) for the treatment of bacterial and fungal keratitis. Acta Biomater. 2021;128:262\u201376. https:\/\/doi.org\/10.1016\/j.actbio.2021.04.014.","journal-title":"Acta Biomater"},{"key":"3368_CR164","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jconrel.2024.03.006","volume":"368","author":"L Gu","year":"2024","unstructured":"Gu L, Lin J, Wang Q, Meng F, Niu G, Lin H, et al. Mesoporous zinc oxide-based drug delivery system offers an antifungal and immunoregulatory strategy for treating keratitis. J Control Release. 2024;368:483\u201397. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.006.","journal-title":"J Control Release"},{"issue":"49","key":"3368_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202206437","volume":"34","author":"J He","year":"2022","unstructured":"He J, Ye Y, Zhang D, Yao K, Zhou M. Visualized gallium\/lyticase\u2010integrated antifungal strategy for fungal keratitis treatment. Adv Mater. 2022;34(49): 2206437. https:\/\/doi.org\/10.1002\/adma.202206437.","journal-title":"Adv Mater"},{"key":"3368_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.110767","volume":"111","author":"D Yan","year":"2020","unstructured":"Yan D, Yao Q, Yu F, Chen L, Zhang S, Sun H, et al. Surface modified electrospun poly (lactic acid) fibrous scaffold with cellulose nanofibrils and Ag nanoparticles for ocular cell proliferation and antimicrobial application. Mater Sci Eng C. 2020;111: 110767. https:\/\/doi.org\/10.1016\/j.msec.2020.110767.","journal-title":"Mater Sci Eng C"},{"key":"3368_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.212771","volume":"136","author":"L Gu","year":"2022","unstructured":"Gu L, Li C, Lin J, Wang Q, Yin M, Zhang L, et al. Drug-loaded mesoporous carbon with sustained drug release capacity and enhanced antifungal activity to treat fungal keratitis. Biomater Adv. 2022;136: 212771. https:\/\/doi.org\/10.1016\/j.bioadv.2022.212771.","journal-title":"Biomater Adv"},{"issue":"7","key":"3368_CR168","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1049\/iet-nbt.2017.0003","volume":"11","author":"M Lachmapure","year":"2017","unstructured":"Lachmapure M, Paralikar P, Palanisamy M, Alves M, Rai M. Efficacy of biogenic silver nanoparticles against clinical isolates of fungi causing mycotic keratitis in humans. IET Nanobiotechnol. 2017;11(7):809\u201314. https:\/\/doi.org\/10.1049\/iet-nbt.2017.0003.","journal-title":"IET Nanobiotechnol"},{"issue":"28","key":"3368_CR169","doi-asserted-by":"publisher","first-page":"8406","DOI":"10.1039\/D5TB00802F","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang Z, Lin J, Wang Q, Zhang L, Yu B, Chi M, et al. ZIF-8-coated ZnO with pH-responsive natamycin release boosting the antifungal and anti-inflammation activity to treat fungal keratitis. J Mater Chem B. 2025;13(28):8406\u201318. https:\/\/doi.org\/10.1039\/D5TB00802F.","journal-title":"J Mater Chem B"},{"issue":"14","key":"3368_CR170","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.3390\/ijms25147794","volume":"25","author":"KW Lee","year":"2024","unstructured":"Lee KW, Chan LK, Hung LC, Phoebe LK, Park Y, Yi KH. Clinical applications of exosomes: a critical review. Int J Mol Sci. 2024;25(14):7794. https:\/\/doi.org\/10.3390\/ijms25147794.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3368_CR171","doi-asserted-by":"publisher","first-page":"10917","DOI":"10.3390\/ijms241310917","volume":"24","author":"B Bhujel","year":"2023","unstructured":"Bhujel B, Oh SH, Kim CM, Yoon YJ, Kim YJ, Chung HS, et al. Mesenchymal stem cells and xosomes: a novel therapeutic approach for corneal diseases. Int J Mol Sci. 2023;24(13):10917. https:\/\/doi.org\/10.3390\/ijms241310917.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3368_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010233","volume":"13","author":"N Blanco-Agud\u00edn","year":"2025","unstructured":"Blanco-Agud\u00edn N, Ye S, Gonz\u00e1lez-Fern\u00e1ndez S, Alcalde I, Merayo-Lloves J, Quir\u00f3s LM. Exosomes in ocular health: recent insights into pathology, diagnostic applications and therapeutic functions. Biomedicines. 2025;13(1): 233. https:\/\/doi.org\/10.3390\/biomedicines13010233.","journal-title":"Biomedicines"},{"issue":"1","key":"3368_CR173","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-023-03744-0.","volume":"206","author":"M Bicer","year":"2024","unstructured":"Bicer M. Exploring therapeutic avenues: mesenchymal stem\/stromal cells and exosomes in confronting enigmatic biofilm-producing fungi. Arch Microbiol. 2024;206(1): 11. https:\/\/doi.org\/10.1007\/s00203-023-03744-0.","journal-title":"Arch Microbiol"},{"issue":"1","key":"3368_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1235-6","volume":"19","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Chen Y, Wang S, Qin F, Wang L. MSCs helped reduce scarring in the cornea after fungal infection when combined with anti-fungal treatment. BMC Ophthalmol. 2019;19(1): 226. https:\/\/doi.org\/10.1186\/s12886-019-1235-6.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"3368_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113222","volume":"417","author":"J Gandhi","year":"2022","unstructured":"Gandhi J, Sushma MV, Rengan AK, Naik MN, Mishra DK, Boyinpally SR, et al. Proteomic profiling of exosomes in a mouse model of Candida albicans endophthalmitis. Exp Cell Res. 2022;417(2): 113222. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113222.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3368_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112393","volume":"398","author":"Q Ji","year":"2021","unstructured":"Ji Q, Liu J, Dong Y, Wang L, Dong K, Setiz B, et al. Exosomes derived from thymic stromal lymphopoietin-treated dendritic cells regulate T helper 17\/regulatory T cell differentiation via miR-21\/Smad7 axis. Exp Cell Res. 2021;398(1): 112393. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112393.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3368_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s44301-025-00008-2","volume":"1","author":"A Fortune","year":"2025","unstructured":"Fortune A, Aime A, Raymond D, Kumar S. Nanotechnology in medicine: a double-edged sword for health outcomes. Health Nanotechnol. 2025;1(1): 9. https:\/\/doi.org\/10.1186\/s44301-025-00008-2.","journal-title":"Health Nanotechnol"},{"issue":"1","key":"3368_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-025-00707-w","volume":"14","author":"TA Oso","year":"2025","unstructured":"Oso TA, Okesanya OJ, Adebayo UO, Ayelaagbe OB, Obadeyi KB, Ogunmuyiwa-James ME, et al. Harnessing nanotechnology to combat antimicrobial-resistant pathogens: a multidisciplinary approach to strengthen global public health defense systems. Beni-Suef Univ J Basic Appl Sci. 2025;14(1): 119. https:\/\/doi.org\/10.1186\/s43088-025-00707-w.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"5","key":"3368_CR179","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","volume":"135","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Spoerl E, Seiler T. Riboflavin\/ultraviolet-A\u2013induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620\u20137. https:\/\/doi.org\/10.1016\/S0002-9394(02)02220-1.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3368_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02380-5","volume":"12","author":"S Liu","year":"2023","unstructured":"Liu S, Fang S, Zhang L. Photoactivated chromophore-corneal cross-linking accelerates corneal healing in fungal keratitis: an updated meta-analysis. Syst Rev. 2023;12(1): 208. https:\/\/doi.org\/10.1186\/s13643-023-02380-5.","journal-title":"Syst Rev"},{"issue":"7","key":"3368_CR181","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.7.14","volume":"13","author":"ME Kowalska","year":"2024","unstructured":"Kowalska ME, Pot SA, Hartnack S. Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL)\u2014a scoping review based on preclinical studies. Transl Vis Sci Technol. 2024;13(7): 14. https:\/\/doi.org\/10.1167\/tvst.13.7.14.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"3368_CR182","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ophtha.2019.08.029","volume":"127","author":"NV Prajna","year":"2020","unstructured":"Prajna NV, Radhakrishnan N, Lalitha P, Austin A, Ray KJ, Keenan JD, et al. Cross-linking\u2013assisted infection reduction: a randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis. Ophthalmology. 2020;127(2):159\u201366. https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.029.","journal-title":"Ophthalmology"},{"issue":"8","key":"3368_CR183","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/ICO.0000000000002973","volume":"41","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Munzinger A, Goldblum D, Hillen M, Tandogan T. Repeated high-fluence accelerated slitlamp-based photoactivated chromophore for keratitis corneal cross-linking for treatment-resistant fungal keratitis. Cornea. 2022;41(8):1058\u201361. https:\/\/doi.org\/10.1097\/ICO.0000000000002973.","journal-title":"Cornea"},{"issue":"4","key":"3368_CR184","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1177\/11206721221092224","volume":"32","author":"R Awad","year":"2022","unstructured":"Awad R, Hafezi F, Ghaith AA, Baddour MM, Awad K, Abdalla M, et al. Comparison between three different high fluence UVA levels in corneal collagen cross-linking for treatment of experimentally induced fungal keratitis in rabbits. Eur J Ophthalmol. 2022;32(4):1907\u201314. https:\/\/doi.org\/10.1177\/11206721221092224.","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"3368_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122011","volume":"13","author":"JH Hung","year":"2021","unstructured":"Hung JH, Lee CN, Hsu HW, Ng IS, Wu CJ, Yu CK, et al. Recent advances in photodynamic therapy against fungal keratitis. Pharmaceutics. 2021;13(12): 2011. https:\/\/doi.org\/10.3390\/pharmaceutics13122011.","journal-title":"Pharmaceutics"},{"key":"3368_CR186","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/OPTH.S447138","volume":"18","author":"R Awad","year":"2024","unstructured":"Awad R, Ghaith AA, Awad K, Mamdouh Saad M, Elmassry AA. Fungal keratitis: diagnosis, management, and recent advances. Clin Ophthalmol. 2024;18:85\u2013106. https:\/\/doi.org\/10.2147\/OPTH.S447138.","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"3368_CR187","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/02713683.2022.2058019","volume":"47","author":"B Bagga","year":"2022","unstructured":"Bagga B, Sharma S, Ahirwar LK, Sheba E, Vaddavalli PK, Mishra DK. Clinical outcomes of rose bengal mediated photodynamic antimicrobial therapy on fungal keratitis with their microbiological and pathological correlation. Curr Eye Res. 2022;47(7):987\u201394. https:\/\/doi.org\/10.1080\/02713683.2022.2058019.","journal-title":"Curr Eye Res"},{"issue":"1","key":"3368_CR188","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ajo.2014.04.007","volume":"158","author":"A Arboleda","year":"2014","unstructured":"Arboleda A, Miller D, Cabot F, Taneja M, Aguilar MC, Alawa K, et al. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol. 2014;158(1):64\u201370. https:\/\/doi.org\/10.1016\/j.ajo.2014.04.007.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"3368_CR189","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1021\/acsnano.1c03508","volume":"15","author":"C Zhou","year":"2021","unstructured":"Zhou C, Peng C, Shi C, Jiang M, Chau JH, Liu Z, et al. Mitochondria-specific aggregation-induced emission luminogens for selective photodynamic killing of fungi and efficacious treatment of keratitis. ACS Nano. 2021;15(7):12129\u201339. https:\/\/doi.org\/10.1021\/acsnano.1c03508.","journal-title":"ACS Nano"},{"issue":"1","key":"3368_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010085","volume":"9","author":"J Park","year":"2021","unstructured":"Park J, Lee YK, Park IK, Hwang SR. Current limitations and recent progress in nanomedicine for clinically available photodynamic therapy. Biomedicines. 2021;9(1): 85. https:\/\/doi.org\/10.3390\/biomedicines9010085.","journal-title":"Biomedicines"},{"issue":"13","key":"3368_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132484","volume":"16","author":"P Alekseeva","year":"2024","unstructured":"Alekseeva P, Makarov V, Efendiev K, Shiryaev A, Reshetov I, Loschenov V. Devices and methods for dosimetry of personalized photodynamic therapy of tumors: a review on recent trends. Cancers. 2024;16(13): 2484. https:\/\/doi.org\/10.3390\/cancers16132484.","journal-title":"Cancers"},{"issue":"2","key":"3368_CR192","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/jop.2019.0034","volume":"36","author":"VL Perez","year":"2020","unstructured":"Perez VL, Wirostko B, Korenfeld M, From S, Raizman M. Ophthalmic drug delivery using iontophoresis: recent clinical applications. J Ocul Pharmacol Ther. 2020;36(2):75\u201387. https:\/\/doi.org\/10.1089\/jop.2019.0034.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"3368_CR193","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2165736","volume":"30","author":"D Wei","year":"2023","unstructured":"Wei D, Pu N, Li SY, Wang YG, Tao Y. Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye. Drug Deliv. 2023;30(1): 2165736. https:\/\/doi.org\/10.1080\/10717544.2023.2165736.","journal-title":"Drug Deliv"},{"issue":"5","key":"3368_CR194","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/17425247.2025.2490267","volume":"22","author":"IP Gross","year":"2025","unstructured":"Gross IP, Lima AL, S\u00e1-Barreto LL, Gelfuso GM, Cunha-Filho M. Recent advances in cutaneous drug delivery by iontophoresis. Expert Opin Drug Deliv. 2025;22(5):633\u201343. https:\/\/doi.org\/10.1080\/17425247.2025.2490267.","journal-title":"Expert Opin Drug Deliv"},{"key":"3368_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118991","volume":"576","author":"GM Gelfuso","year":"2020","unstructured":"Gelfuso GM, Ferreira-Nunes R, Dalmolin LF, Re AC, Dos Santos GA, de S\u00e1 FA, et al. Iontophoresis enhances voriconazole antifungal potency and corneal penetration. Int J Pharm. 2020;576: 118991. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118991.","journal-title":"Int J Pharm"},{"issue":"1","key":"3368_CR196","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40662-021-00272-0","volume":"9","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Hosny M, Shetty R, Knyazer B, Chen S, Wang Q, et al. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye Vision. 2022;9(1):2. https:\/\/doi.org\/10.1186\/s40662-021-00272-0.","journal-title":"Eye Vision"},{"issue":"5","key":"3368_CR197","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.tim.2021.09.007","volume":"30","author":"A Bruch","year":"2022","unstructured":"Bruch A, Kelani AA, Blango MG. RNA-based therapeutics to treat human fungal infections. Trends Microbiol. 2022;30(5):411\u201320. https:\/\/doi.org\/10.1016\/j.tim.2021.09.007.","journal-title":"Trends Microbiol"},{"issue":"8","key":"3368_CR198","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics\u2014challenges and potential solutions. Nat Rev Drug Discov. 2021;20(8):629\u201351. https:\/\/doi.org\/10.1038\/s41573-021-00219-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3368_CR199","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/icb.2011.49","volume":"90","author":"H Guo","year":"2012","unstructured":"Guo H, Gao J, Wu X. Toll-like receptor 2 siRNA suppresses corneal inflammation and attenuates Aspergillus fumigatus keratitis in rats. Immunol Cell Biol. 2012;90(3):352\u20137. https:\/\/doi.org\/10.1038\/icb.2011.49.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"3368_CR200","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.1.24","volume":"62","author":"Q Guo","year":"2021","unstructured":"Guo Q, Lin Y, Hu J. Inhibition of miR-665-3p enhances autophagy and alleviates inflammation in Fusarium solani-induced keratitis. Invest Ophthalmol Vis Sci. 2021;62(1): 24. https:\/\/doi.org\/10.1167\/iovs.62.1.24.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3368_CR201","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12951-022-01658-5","volume":"20","author":"L Fang","year":"2022","unstructured":"Fang L, Liu J, Liu Z, Zhou H. Immune modulating nanoparticles for the treatment of ocular diseases. J Nanobiotechnology. 2022;20(1):496. https:\/\/doi.org\/10.1186\/s12951-022-01658-5.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"3368_CR202","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12886-018-0754-x","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liang Q, Liu Y, Pan Z, Baudouin C, Labb\u00e9 A, et al. Expression of cytokines in aqueous humor from fungal keratitis patients. BMC Ophthalmol. 2018;18(1):105. https:\/\/doi.org\/10.1186\/s12886-018-0754-x.","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"3368_CR203","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/pharmaceutics17101326","volume":"17","author":"MS Hassan","year":"2025","unstructured":"Hassan MS, Zhong C, Hassan F, Li SK. Targeting the eye: RNA-based therapies, interferences, and delivery strategies. Pharmaceutics. 2025;17(10):1326. https:\/\/doi.org\/10.3390\/pharmaceutics17101326.","journal-title":"Pharmaceutics"},{"key":"3368_CR204","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128391408250804231522","author":"KK Sharma","year":"2025","unstructured":"Sharma KK, Durgapal S, Tyagi SJ, Varshney P, Kumar G. Innovations in mRNA-based nanoparticle for the treatment of ocular disorders: a comprehensive review. Curr Pharm Des. 2025. https:\/\/doi.org\/10.2174\/0113816128391408250804231522.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"3368_CR205","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.tibtech.2024.05.002","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Shi Y, Khan MM, Xiao F, Chen W, Tao W, et al. Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases. Trends Biotechnol. 2024;42(11):1439\u201352. https:\/\/doi.org\/10.1016\/j.tibtech.2024.05.002.","journal-title":"Trends Biotechnol"},{"issue":"9","key":"3368_CR206","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29533","volume":"14","author":"VB Wasnik","year":"2022","unstructured":"Wasnik VB, Thool AR. Ocular gene therapy: a literature review with focus on current clinical trials. Cureus. 2022;14(9): e29533. https:\/\/doi.org\/10.7759\/cureus.29533.","journal-title":"Cureus"},{"key":"3368_CR207","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/OPTH.S364200","volume":"16","author":"HH Ghoraba","year":"2022","unstructured":"Ghoraba HH, Akhavanrezayat A, Karaca I, Yavari N, Lajevardi S, Hwang J, et al. Ocular gene therapy: a literature review with special focus on immune and inflammatory responses. Clin Ophthalmol. 2022;16:1753\u201371. https:\/\/doi.org\/10.2147\/OPTH.S364200.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"3368_CR208","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.ymthe.2022.04.002","volume":"30","author":"K Cornetta","year":"2022","unstructured":"Cornetta K, Bonamino M, Mahlangu J, Mingozzi F, Rangarajan S, Rao J. Gene therapy access: global challenges, opportunities, and views from Brazil, South Africa, and India. Mol Ther. 2022;30(6):2122\u20139. https:\/\/doi.org\/10.1016\/j.ymthe.2022.04.002.","journal-title":"Mol Ther"},{"issue":"6","key":"3368_CR209","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4155\/tde-2020-0034","volume":"11","author":"S Hejmady","year":"2020","unstructured":"Hejmady S, Singhvi G, Saha RN, Dubey SK. Regulatory aspects in process development and scale-up of nanopharmaceuticals. Ther Deliv. 2020;11(6):341\u20133. https:\/\/doi.org\/10.4155\/tde-2020-0034.","journal-title":"Ther Deliv"},{"key":"3368_CR210","doi-asserted-by":"publisher","unstructured":"T\u00fcreli NG, T\u00fcreli AE (2020) Chapter 11\u2014Upscaling and GMP production of pharmaceutical drug delivery systems. In: Shegokar R editor. Drug Delivery Trends. Amsterdam, The Netherlands: Elsevier; p. 215\u2013229.  https:\/\/doi.org\/10.1016\/B978-0-12-817870-6.00011-0.","DOI":"10.1016\/B978-0-12-817870-6.00011-0"},{"key":"3368_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114867","volume":"198","author":"P Agarwal","year":"2023","unstructured":"Agarwal P, Rupenthal ID. Non-aqueous formulations in topical ocular drug delivery\u2013a paradigm shift? Adv Drug Deliv Rev. 2023;198: 114867. https:\/\/doi.org\/10.1016\/j.addr.2023.114867.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3368_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00745-9","volume":"19","author":"S Swetledge","year":"2021","unstructured":"Swetledge S, Jung JP, Carter R, Sabliov C. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. J Nanobiotechnol. 2021;19(1): 10. https:\/\/doi.org\/10.1186\/s12951-020-00745-9.","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"3368_CR213","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/polym11081371","volume":"11","author":"C Lynch","year":"2019","unstructured":"Lynch C, Kondiah PP, Choonara YE, du Toit LC, Ally N, Pillay V. Advances in biodegradable nano-sized polymer-based ocular drug delivery. Polymers. 2019;11(8):1371. https:\/\/doi.org\/10.3390\/polym11081371.","journal-title":"Polymers"},{"key":"3368_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.931759","volume":"9","author":"C Yang","year":"2022","unstructured":"Yang C, Yang J, Lu A, Gong J, Yang Y, Lin X, et al. Nanoparticles in ocular applications and their potential toxicity. Front Mol Biosci. 2022;9: 931759. https:\/\/doi.org\/10.3389\/fmolb.2022.931759.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"3368_CR215","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3109\/17435390.2016.1153165","volume":"10","author":"NK Mehra","year":"2016","unstructured":"Mehra NK, Cai D, Kuo L, Hein T, Palakurthi S. Safety and toxicity of nanomaterials for ocular drug delivery applications. Nanotoxicology. 2016;10(7):836\u201360. https:\/\/doi.org\/10.3109\/17435390.2016.1153165.","journal-title":"Nanotoxicology"},{"issue":"1","key":"3368_CR216","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01974-4","volume":"21","author":"J Wei","year":"2023","unstructured":"Wei J, Mu J, Tang Y, Qin D, Duan J, Wu A. Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy. J Nanobiotechnology. 2023;21(1): 282. https:\/\/doi.org\/10.1186\/s12951-023-01974-4.","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"3368_CR217","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1007\/s13346-024-01756-x","volume":"15","author":"S Khan","year":"2025","unstructured":"Khan S, Do CW, Ho EA. Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders. Drug Deliv Transl Res. 2025;15(6):1828\u201376. https:\/\/doi.org\/10.1007\/s13346-024-01756-x.","journal-title":"Drug Deliv Transl Res"},{"issue":"7","key":"3368_CR218","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","volume":"14","author":"H Ragelle","year":"2017","unstructured":"Ragelle H, Danhier F, Pr\u00e9at V, Langer R, Anderson DG. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opin Drug Deliv. 2017;14(7):851\u201364. https:\/\/doi.org\/10.1080\/17425247.2016.1244187.","journal-title":"Expert Opin Drug Deliv"},{"key":"3368_CR219","doi-asserted-by":"publisher","unstructured":"de Souza Cardoso Delfino C, de Paula Pereira MC, dos Santos Oliveira M, de Carvalho Favareto I, Vallad\u00e3o VS, de Oliveira Mota M et al (2025) Scaling nanopharmaceutical production for personalized medicine: challenges and strategies. J Nanopart Res 27(4):1\u20139.  https:\/\/doi.org\/10.1007\/s11051-025-06293-3.","DOI":"10.1007\/s11051-025-06293-3"},{"issue":"4","key":"3368_CR220","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/jof6040349","volume":"6","author":"K Hussain","year":"2020","unstructured":"Hussain K, Malavia D, Johnson EM, Littlechild J, Winlove CP, Vollmer F, et al. Biosensors and diagnostics for fungal detection. J Fungi. 2020;6(4):349. https:\/\/doi.org\/10.3390\/jof6040349.","journal-title":"J Fungi"},{"issue":"17","key":"3368_CR221","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/polym14173580.","volume":"14","author":"SB Dludla","year":"2022","unstructured":"Dludla SB, Mashabela LT, Ng\u2019andwe B, Makoni PA, Witika BA. Current advances in nano-based and polymeric stimuli-responsive drug delivery targeting the ocular microenvironment: a review and envisaged future perspectives. Polymers. 2022;14(17):3580. https:\/\/doi.org\/10.3390\/polym14173580.","journal-title":"Polymers"},{"issue":"10","key":"3368_CR222","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/microorganisms7100457.","volume":"7","author":"JD Lightfoot","year":"2019","unstructured":"Lightfoot JD, Fuller KK. CRISPR\/Cas9-mediated gene replacement in the fungal keratitis pathogen Fusarium solani var. petroliphilum. Microorganisms. 2019;7(10):457. https:\/\/doi.org\/10.3390\/microorganisms7100457.","journal-title":"Microorganisms"},{"issue":"1","key":"3368_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03230-3","volume":"23","author":"S Qu","year":"2025","unstructured":"Qu S, Zheng S, Muhammad S, Huang L, Guo B. An exploration of the ocular mysteries linking nanoparticles to the patho-therapeutic effects against keratitis. J Nanobiotechnology. 2025;23(1): 184. https:\/\/doi.org\/10.1186\/s12951-025-03230-3.","journal-title":"J Nanobiotechnology"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03368-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:49:56Z","timestamp":1780390196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":223,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3368"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03368-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors agreed with the content, and all gave explicit consent to submit the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors confirm that they have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"114"}}